We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YEXT:NYSEYext, Inc. Analysis

Data as of 2026-05-12 - not real-time

$3.78

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Yext is trading below its short‑term moving average and well under its long‑term average, confirming a bearish technical stance. The price sits near a key support level while the recent resistance has been breached, and the RSI sits in a neutral zone, suggesting limited upside momentum. A modestly positive MACD histogram provides a hint of short‑term bullish pressure, but the overall trend remains down‑ward and volatility is markedly high, with beta hovering around market levels. Fundamentally, revenue growth is flat and operating margins are negative, while the company carries a high debt‑to‑equity ratio that outweighs its cash position. The current price exceeds the discounted cash‑flow fair‑value estimate, and the trailing price‑to‑earnings multiple is well above the industry average, indicating a premium valuation. However, the forward earnings multiple is dramatically lower, reflecting expectations of earnings acceleration. Recent news highlights renewed short‑interest activity, institutional buying, and management commentary on cost discipline, which have sparked investor interest despite mixed analyst viewpoints. Bullish voices cite stable large‑customer metrics and early traction in new product lines, whereas skeptics point to sub‑par fourth‑quarter fundamentals and uncertainty surrounding a possible management buyout. The sector is experiencing strong AI‑driven demand, offering a potential growth catalyst for Yext’s digital knowledge platform. Overall, the stock sits at a crossroads between short‑term technical weakness and longer‑term growth narratives.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near technical support
  • bearish moving‑average alignment
  • elevated volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • forward earnings multiple suggests upside
  • institutional buying and short‑interest shift
  • potential AI‑driven demand for the platform

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • strategic positioning in enterprise search
  • cost discipline and improving cash flow trends
  • possible value unlock from management buyout speculation

Key Metrics & Analysis

Financial Health

Revenue Growth-1.00%
Profit Margin8.48%
P/E Ratio54.0
ROE24.23%
ROA-0.09%
Debt/Equity111.94
P/B Ratio2.9
Op. Cash Flow$55.8M
Free Cash Flow$28.3M
Industry P/E39.0

Technical Analysis

TrendBearish
RSI41.4
Support$3.42
Resistance$4.21
MA 20$3.88
MA 50$4.35
MA 200$7.08
MACDBullish
VolumeStable
Fear & Greed Index88.61

Valuation

Fair Value$3.54
Target Price$7.50
Upside/Downside98.41%
GradeFair
TypeBlend

Risk Assessment

Beta0.92
Volatility55.53%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.